查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1692368

退伍軍人症桿菌檢測市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、最終用途（微生物培養、直接螢光抗體染色、PCR、其他）、按地區和競爭細分，2020-2030 年預測

Legionella Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End Use (Microbial culture, Direct fluorescent antibody stain, PCR, Others), By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球 退伍軍人症桿菌檢測市場價值為 2.8425 億美元，預計到 2030 年將達到 4.8715 億美元，預測期內複合年成長率為 9.39%。全球 退伍軍人症桿菌檢測市場是指用於檢測和監測 退伍軍人症桿菌細菌（特別是導致軍團病的嗜肺 退伍軍人症桿菌種）的診斷測試和服務市場。退伍軍人症是一種嚴重的肺炎，可透過吸入受污染的水滴感染，通常來自冷卻水塔、熱水浴缸和管道系統等來源。據美國疾病管制與預防中心稱，2018 年報告了約 10,000 例軍團病病例。

市場概況
預測期 2026-2030
2024 年市場規模 2.8425億美元
2030 年市場規模 4.8715億美元
2025-2030 年複合年成長率 9.39％
成長最快的領域 聚合酶連鎖反應
最大的市場 亞太地區

退伍軍人症桿菌在熱水環境中旺盛生長，使得依賴儲水的產業（如學校、餐廳、醫院和大型管線系統）特別容易受到 退伍軍人症桿菌的污染。因此，這些產業對於 退伍軍人症桿菌及其相關感染的準確、及時診斷的需求日益成長。 2022年9月，阿根廷聖米格爾德圖庫曼爆發嚴重肺炎，造成4人死亡，11人重症。後來，人們將這次疫情與 退伍軍人症桿菌，特別是嗜肺 退伍軍人症桿菌連結起來。此外，2022 年 6 月，紐約州總檢察長與 Verizon 達成協議，確保該公司採取迅速全面的行動，防止退伍軍人病在整個紐約州蔓延。

主要市場促進因素

測試技術的進步

主要市場挑戰

缺乏標準化測試協議

主要市場趨勢

快速診斷測試

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第 5 章：全球 退伍軍人症桿菌檢測市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型（水質檢測、IVD檢測）
    • 依最終用途（微生物培養、直接螢光抗體 (DFA) 染色、PCR、其他）
    • 按地區
    • 按公司分類（2024）
  • 產品市場圖
    • 按類型
    • 按最終用途
    • 按地區

第 6 章：北美 退伍軍人症桿菌檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第 7 章：歐洲 退伍軍人症桿菌檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 法國
    • 義大利
    • 西班牙

第 8 章：亞太 退伍軍人症桿菌檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 日本
    • 印度
    • 澳洲
    • 韓國

第 9 章：南美洲 退伍軍人症桿菌檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲 退伍軍人症桿菌檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 合併與收購
  • 產品發布

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • BIOMERIEUX SA
  • Eiken Chemical Co., Ltd
  • Hologic Inc.
  • Pro-Lab PLC
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 20921

Global Legionella Testing Market was valued at USD 284.25 million in 2024 and is expected to reach USD 487.15 million by 2030 with a CAGR of 9.39% during the forecast period. The Global Legionella Testing Market refers to the market for diagnostic tests and services used to detect and monitor Legionella bacteria, particularly the Legionella pneumophila species, responsible for causing Legionnaires' disease. Legionnaires' disease is a severe form of pneumonia that can be contracted through inhalation of contaminated water droplets, typically from sources like cooling towers, hot tubs, and plumbing systems. According to the Centers for Disease Control and Prevention, approximately 10,000 cases of Legionnaires' disease were reported in 2018.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 284.25 Million
Market Size 2030USD 487.15 Million
CAGR 2025-20309.39%
Fastest Growing SegmentPCR
Largest MarketAsia Pacific

Legionella bacteria thrive in hot water conditions, making industries that rely on water storage, such as schools, restaurants, hospitals, and large plumbing systems, particularly susceptible to Legionella contamination. As a result, there is a growing demand across these industries for accurate and timely diagnosis of Legionella and related infections. In September 2022, an outbreak of severe pneumonia in San Miguel de Tucuman, Argentina, resulted in four deaths and 11 cases of severe illness. This outbreak was later linked to Legionella, specifically the bacterium L. pneumophila. Additionally, in June 2022, the New York Attorney General reached an agreement with Verizon to ensure the company takes swift and comprehensive action to prevent the spread of Legionnaires' disease throughout New York State.

Key Market Drivers

Advances in Testing Technologies

The Global Legionella Testing Market is experiencing substantial growth, and one of the key drivers behind this expansion is the continuous advancement of testing technologies. Legionella, a bacterium responsible for Legionnaires' disease, poses a significant public health risk. The need for rapid, sensitive, and accurate testing methods has driven innovation in the field.

Traditional methods of detecting Legionella bacteria, such as culture-based techniques, can be time-consuming and may not always yield accurate results. In contrast, modern molecular techniques, particularly Polymerase Chain Reaction (PCR), have revolutionized Legionella testing. PCR allows for the rapid and precise detection of Legionella DNA in water and environmental samples, significantly reducing the time required for diagnosis. The ability to provide quicker and more accurate results is a key factor driving the demand for Legionella testing services.

The sensitivity of testing methods is crucial when dealing with potentially harmful microorganisms like Legionella. Advances in testing technologies have led to the development of highly sensitive assays. These assays can detect even trace amounts of Legionella bacteria in various samples, including water systems, cooling towers, and air. Enhanced sensitivity ensures that potential sources of contamination are not overlooked, thereby improving the overall safety of water systems.

Automation in testing technologies has not only sped up the testing process but has also minimized the potential for human error. Automated platforms reduce the manual handling of samples, leading to greater consistency and reliability in test results. This feature is especially important in Legionella testing, where accuracy is critical for public health and safety.

Key Market Challenges

Lack of Standardized Testing Protocols

One of the primary challenges in the Legionella testing industry is the absence of standardized testing protocols. Different laboratories and testing facilities may use varying methods and equipment, leading to potential inconsistencies in results. Standardization is crucial to ensure that test results are accurate and can be reliably interpreted.

Key Market Trends

Rapid Diagnostic Tests

Rapid diagnostic tests are set to revolutionize the Legionella Testing Market. These tests offer quicker results, typically within hours, as opposed to the days required by traditional methods. Their speed and accuracy make them invaluable for timely decision-making in Legionella risk management. As demand for fast and reliable testing increases, rapid diagnostic tests will likely gain significant traction.

Key Market Players

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • BIOMERIEUX SA
  • Eiken Chemical Co., Ltd
  • Hologic Inc.
  • Pro-Lab PLC
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Legionella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Legionella Testing Market, By Type:

  • Water testing
  • IVD testing

Legionella Testing Market, By End Use:

  • Microbial culture
  • Direct fluorescent antibody (DFA) stain
  • PCR
  • Others

Legionella Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Legionella Testing Market.

Available Customizations:

Global Legionella Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Legionella Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Water testing, IVD testing)
    • 5.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Type
    • 5.3.2. By End Use
    • 5.3.3. By Region

6. North America Legionella Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Water testing, IVD testing)
    • 6.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Legionella Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Legionella Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Legionella Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End Use

7. Europe Legionella Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Water testing, IVD testing)
    • 7.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Legionella Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End Use
    • 7.3.2. United Kingdom Legionella Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End Use
    • 7.3.3. France Legionella Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Legionella Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Legionella Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End Use

8. Asia-Pacific Legionella Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Water testing, IVD testing)
    • 8.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Legionella Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End Use
    • 8.3.2. Japan Legionella Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End Use
    • 8.3.3. India Legionella Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End Use
    • 8.3.4. Australia Legionella Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End Use
    • 8.3.5. South Korea Legionella Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End Use

9. South America Legionella Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Water testing, IVD testing)
    • 9.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Legionella Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Legionella Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Legionella Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Legionella Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Water testing, IVD testing)
    • 10.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Legionella Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Legionella Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Legionella Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End Use
    • 10.3.4. Kuwait Legionella Testing Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Abbott Laboratories
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Recent Developments
    • 14.1.5. Financials (As Reported)
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Beckman Coulter, Inc.
  • 14.3. Bio-Rad Laboratories Inc.
  • 14.4. BIOMERIEUX SA
  • 14.5. Eiken Chemical Co., Ltd
  • 14.6. Hologic Inc.
  • 14.7. Pro-Lab PLC
  • 14.8. QIAGEN N.V.
  • 14.9. F. Hoffmann-La Roche Ltd
  • 14.10. Takara Bio Inc.
  • 14.11. Thermo Fisher Scientific Inc.

15. Strategic Recommendations

16. About Us & Disclaimer